ROCKET PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.72 USD | -2.61% |
|
-3.20% | -24.19% |
| May. 10 | UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating | MT |
| May. 10 | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 25.35 | 31.94 | 30.53 |
| Spread/Res. | -10.37% | -28.87% | -25.58% |
| Spread/Supp. | +5.58% | +25.04% | +7.17% |
| Support | 21.52 | 18.17 | 21.20 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RCKT Stock
- Charts Rocket Pharmaceuticals, Inc.